Kristine Badin, MD
Hematology & Oncology · Jersey City, NJNPI 1417364456
Payments from drug & device makers
Across 79 payments — averaging $56.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Onmark, Inc.$3K
- AstraZeneca$346
- E.r. Squibb & Sons, L.L.C.$208
- Amgen$183
- Merck$140
- Incyte Corporation$90
- plus $447 from 20 others
What the payments were for
- Travel & lodging$1,59836%
- Food & beverage$2,75862%
- Education$952%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Onmark, Inc. | 10 | $3,057 |
| AstraZeneca | 9 | $346 |
| E.r. Squibb & Sons, L.L.C. | 7 | $208 |
| Amgen | 6 | $183 |
| Merck | 11 | $140 |
| Incyte Corporation | 6 | $90 |
| Bayer | 4 | $69 |
| Boehringer Ingelheim | 4 | $56 |
| Adaptive Biotechnologies Corporation | 2 | $35 |
| AVEO Pharmaceuticals, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $28 |
| Rigel Pharmaceuticals, Inc. | 2 | $26 |
| Pfizer | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Sobi, Inc | 1 | $14 |
| Octapharma USA, Inc. | 1 | $13 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Exelixis Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,471 in reported general payments places this provider in the 45th percentile of 362 hematology & oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 12 | $129 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Jersey City
- Amit PatelJersey City$770K
- Bruno FangEast Brunswick$8.5M
- Charles FarberMorristown$4.6M
- Rajat BannerjiNew Brunswick$3.3M
- Eleonora TeplinskyParamus$2.6M
- Mohamad CherryMorristown$1.9M
- Evan NaylorManahawkin$1.3M
- James OrsiniBelleville$1.3M
- Eli KirshnerWestwood$1.2M
- Linda DanieuLivingston$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.